Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

G L Snyder, R W Keller Jr and M J Zigmond
Journal of Pharmacology and Experimental Therapeutics May 1990, 253 (2) 867-876;
G L Snyder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R W Keller Jr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M J Zigmond
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In this study, we have examined the spontaneous efflux and stimulation-induced overflow of endogenous dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) from striatal slices prepared from adult rats. Partial destruction of striatal DA terminals with 6-hydroxydopamine reduced the electrically evoked overflow of DA and DOPAC, but by less than the DA content of the tissue slices. This resulted in an increase in the fractional overflow of DA and DOPAC, a measure of overflow from residual dopaminergic terminals. The increase in fractional DA overflow was related to the lesion size, reaching 7-fold with DA depletions of greater than 90%. Inhibition of DA re-uptake with nomifensine (10 microM) increased DA overflow and reduced DOPAC overflow by an equivalent amount, indicating that a portion of the DA released by electrical stimulation is recaptured and metabolized before appearing as DOPAC in the superfusate. However, 6-hydroxydopamine lesions further elevated fractional DA overflow above control even in the presence of nomifensine, suggesting that slices prepared from lesioned animals exhibit an increase in DA release from residual dopaminergic terminals. DA overflow was enhanced by the DA receptor antagonist sulpiride (1 microM) in control tissue but not in slices prepared from lesioned animals, suggesting that increased efflux per terminal was accompanied by reduced autoinhibition of release. Over a range of firing frequencies typical of nigrostriatal neurons in vivo (2-8 Hz), fractional DA overflow per pulse from lesioned slices was 3-fold higher than control overflow; however, fractional overflow per pulse was reduced from lesioned but not control slices when slices were exposed to a higher frequency (12 Hz). Thus, the lesion appeared to have increased DA release at moderate frequencies, but had reduced the effective range of frequencies over which the DA terminals could operate. Finally, 3-iodotyrosine (2 mM), an inhibitor of tyrosine hydroxylase, reduced DA overflow from intact slices, but completely abolished overflow from lesioned slices, suggesting that 6-hydroxydopamine had increased the dependence of DA efflux on a sustained rate of DA synthesis. Taken together, these data suggest that after lesioning with 6-hydroxydopamine, DA released per pulse from residual terminals is increased relative to control, so long as the stimulation frequency is within the physiological range. This increase in release may serve a compensatory function, maintaining dopaminergic control over striatal function despite extensive loss of DA neurons.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 253, Issue 2
1 May 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

G L Snyder, R W Keller and M J Zigmond
Journal of Pharmacology and Experimental Therapeutics May 1, 1990, 253 (2) 867-876;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

G L Snyder, R W Keller and M J Zigmond
Journal of Pharmacology and Experimental Therapeutics May 1, 1990, 253 (2) 867-876;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics